Issues & Trends

MIRAE ASSET SECURITIES Decides to Cancel 500 Billion Won Worth of Treasury Stock

"Reflects a commitment to doing our utmost to protect shareholders' rights"

Kwon Oh Seok
2026-07-23 18:22:59
[Edaily Reporter Kwon Oh Seok ] MIRAE ASSET SECURITIES(006800)announced that it held a board of directors meeting on the 23rd and resolved to cancel a total of 26,396,296 treasury shares, consisting of 16,545,829 common shares and 9,850,467 preferred shares.
(Photo = E-Daily DB Inc.)

The preferred shares to be canceled consist of 621,617 shares of MIRAE ASSET SECURITIES(1P) and 9,228,850 shares of MIRAE ASSET SECURITIES(2PB). The total value of the cancellation is approximately 502,359,920,000 won, and the scheduled cancellation date is the 31st of this month.
This marks the second decision to cancel treasury stock this year; the company previously canceled 11,947,808 shares (131.8 billion won) in February. A MIRAE ASSET SECURITIES official stated, “This treasury stock cancellation reflects our commitment to doing our utmost to protect shareholder rights,” adding, “We will continue to pursue a consistent and faithful shareholder return policy and do our best to achieve shared growth with our shareholders.”

Economy

Corporation

IT·Science

Economy

From Buildings to Operating Companies… Rental Housing Platforms Swallowed Whole

The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
2026-08-11 00:34:03

Corporation

SK hynix Responds to Rumors of Chongqing Plant Stake Sale: "Nothing Has Been Finalized"

SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
2026-08-10 18:53:57

IT·Science

Medy-Tox Inc. Reports 11% Increase in Second-Quarter Revenue… ‘NewViju’ Emerges as New Growth Engine

Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …
2026-08-10 17:02:01